Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2011 Scrip 100: Surfing the social media wave

This article was originally published in Scrip

Executive Summary

Pharma should be chomping at the bit to incorporate social media channels into its marketing plans, but hesitance remains. What is holding industry back, and how can it seize Web 2.0 opportunities in the future, asks Rebecca Debens.

You may also be interested in...



2011 Scrip Asia 100 - Hutchison MediPharma proves concept that China can innovate

Collaborations with big pharma, healthy venture investments and a robust pipeline make Shanghai-based Hutchison MediPharma a blueprint for Asian bioventures. CEO Dr Samantha Du discusses with Rebecca Debens deals, drug development and doing business in China. This article is part of the 2011 Scrip Asia 100.

Topics

Related Companies

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel